Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Review: Transdermal Patch


Affiliations
1 Bapatla College of Pharmacy, Bapatla, Guntur (D.T), Andhra Pradesh, India
     

   Subscribe/Renew Journal


Transdermal drug delivery systems (TDDS) or “patches,” are dosage forms designed to deliver effective amount of drug across a patient’s skin. In order to deliver therapeutic agents through the human skin for systemic effects, the comprehensive morphological, biophysical and physicochemical properties of the skin are to be considered. Transdermal delivery is advantageous over injectables and oral routes by increasing patient compliance and avoiding first pass metabolism respectively. Several important advantages of transdermal drug delivery are limitation of hepatic first pass metabolism, enhancement of therapeutic efficiency and maintenance of steady plasma level of the drug. The evidence of percutaneous drug absorption found through measurable blood levels of the drug, detectable excretion of the drug and its metabolites in the urine and through the clinical response of the patient to the administered drug therapy.

Keywords

TDDS, Evaluations.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Rhaghuram reddy k, Muttalik S and Reddy S. Once – daily sustained- release matrix tablets of nicorandil: formulation and invitro evaluation. AAPS Pharm.Sci.Tech. 2003;4:4.
  • Shaila L, Pandey S and Udupa N. Design and evaluation of matrix type membrane controlled Transdermal drug delivery system of nicotin suitable for use in smoking cessation. Indian Journ. Pharm. Sci. 2006;68: 179-184
  • Aarti N, Louk A.R.M.P, Russsel.O.P and Richard H.G. Mechanism of oleic acid induced skin permeation enhancement in vivo in humans. Jour. control. Release 1995; 37: 299-306.
  • Wade A and Weller P.J. Handbook of pharmaceutical Excipients. Washington, DC: American Pharmaceutical Publishing Association 1994; 362-366.
  • Lec S.T, Yac S.H, Kim S.W and Berner B. One way membrane for Transdermal drug delivery systems / system optimization. Int. J Pharm. 1991; 77: 231 - 237.
  • Vyas S.P and Khar R.K. Targetted and controlled Drug Delivery Novel carrier system1st Ed., CBS Publishers and distributors, New Delhi, 2002; 411- 447.
  • Singh J, Tripathi K.T and SakiaT.R. Effect of penetration enhancers on the invitro transport of ephedrine through rate skin and human epidermis from matrix based Transdermal formulations. Drug Dev.Ind. Pharm. 1993; 19: 1623-1628.
  • Wade A, Weller P.J. Handbook of pharmaceutical Excipients Washington, DC: American Pharmaceutical Publishing Association; 1994: 362- 366

Abstract Views: 579

PDF Views: 0




  • Review: Transdermal Patch

Abstract Views: 579  |  PDF Views: 0

Authors

T. Venkateswara Rao
Bapatla College of Pharmacy, Bapatla, Guntur (D.T), Andhra Pradesh, India
Ravi Kiran Owku
Bapatla College of Pharmacy, Bapatla, Guntur (D.T), Andhra Pradesh, India

Abstract


Transdermal drug delivery systems (TDDS) or “patches,” are dosage forms designed to deliver effective amount of drug across a patient’s skin. In order to deliver therapeutic agents through the human skin for systemic effects, the comprehensive morphological, biophysical and physicochemical properties of the skin are to be considered. Transdermal delivery is advantageous over injectables and oral routes by increasing patient compliance and avoiding first pass metabolism respectively. Several important advantages of transdermal drug delivery are limitation of hepatic first pass metabolism, enhancement of therapeutic efficiency and maintenance of steady plasma level of the drug. The evidence of percutaneous drug absorption found through measurable blood levels of the drug, detectable excretion of the drug and its metabolites in the urine and through the clinical response of the patient to the administered drug therapy.

Keywords


TDDS, Evaluations.

References